Response of refractory residual ocular symptoms to efgartigimod in generalized myasthenia gravis: A real-world case series. He D, Zhou Y, Zhang Y, Zhang J, et al. J Neuroimmunol 2025;401:578558.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

He D, Zhou Y, Zhang Y, Zhang J, et al. Response of refractory residual ocular symptoms to efgartigimod in generalized myasthenia gravis: A real-world case series. J Neuroimmunol 2025;401:578558.
PMID: 39999710